BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8584586)

  • 21. Early detection and intervention in schizophrenia.
    Linszen DH; Dingemans PM; Lenior ME; Scholte WF; de Haan L; Goldstein MJ
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S31-4. PubMed ID: 9690968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose depot medication in schizophrenia.
    Burnett PL; Galletly CA; Moyle RJ; Clark CR
    Schizophr Bull; 1993; 19(1):155-64. PubMed ID: 8095736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional antipsychotic medications for schizophrenia.
    Dixon LB; Lehman AF; Levine J
    Schizophr Bull; 1995; 21(4):567-77. PubMed ID: 8749885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing dosage in maintenance treatment of schizophrenia. Review and prognosis.
    Schooler NR
    Br J Psychiatry Suppl; 1993 Dec; (22):58-65. PubMed ID: 7906525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia.
    Wiedemann G; Hahlweg K; Müller U; Feinstein E; Hank G; Dose M
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):72-84. PubMed ID: 11407442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1987; 13(1):133-56. PubMed ID: 2885912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The social status of schizophrenic patients].
    Müller P; Gaebel W; Bandelow B; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Tegeler J
    Nervenarzt; 1998 Mar; 69(3):204-9. PubMed ID: 9565974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent vs maintenance medication in schizophrenia. Two-year results.
    Herz MI; Glazer WM; Mostert MA; Sheard MA; Szymanski HV; Hafez H; Mirza M; Vana J
    Arch Gen Psychiatry; 1991 Apr; 48(4):333-9. PubMed ID: 1672588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psychoeducational-psychotherapeutic treatment of schizophrenic patients and their caregivers. Results of a 1-year catamnestic study].
    Hornung WP; Holle R; Schulze Mönking H; Klingberg S; Buchkremer G
    Nervenarzt; 1995 Nov; 66(11):828-34. PubMed ID: 8532099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressed emotion, communication deviance and schizophrenia. An exploratory study of the relationship between two family variables and the course and outcome of a psychoeducational treatment programme.
    Rund BR; Oie M; Borchgrevink TS; Fjell A
    Psychopathology; 1995; 28(4):220-8. PubMed ID: 7480578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial treatments for schizophrenia.
    Liberman RP
    Psychiatry; 1994 May; 57(2):104-14. PubMed ID: 7938330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication.
    de Haan L; Linszen DH; Lenior ME; de Win ED; Gorsira R
    Schizophr Bull; 2003; 29(2):341-8. PubMed ID: 14552508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deliverability of psychoeducational family management.
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Schizophr Bull; 1994; 20(3):547-56. PubMed ID: 7973470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence studies in schizophrenia.
    Hamann J; Pitschel-Walz G; Kissling W
    Am J Psychiatry; 2004 Mar; 161(3):582; author reply 582-3. PubMed ID: 14992997
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.